Roche (RHHBY) and NuGEN Technologies, Inc. Develop Whole Transcriptome Profiling Solution for 454 Sequencing Systems
4/5/2011 9:00:22 AM
BRANFORD, Conn. & San Carlos, Calif.--(BUSINESS WIRE)--454 Life Sciences, a Roche Company, and NuGEN Technologies, announced today the development of a unique sample preparation method and high-throughput sequencing solution for small and degraded RNA samples. The collaboration leverages 454 Life Sciences’ capabilities to construct sequencing-ready cDNA libraries from RNA samples and NuGEN’s experience and innovation with genomic sample preparation solutions. This collaborative effort provides researchers an end-to-end solution for transcriptome profiling using their most precious sample types.
comments powered by